STAT
NOVEMBER 21, 2023
Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to get vaccinated, fulfilling a long-standing ambition of pharmacists to provide more expansive clinical services.
PharmaVoice
NOVEMBER 21, 2023
Connie Chang, COO at ONL Therapeutics, describes what it takes to bring a CEO’s vision to life.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 21, 2023
Few people leave the world with as much grace or influence as Rosalynn Smith Carter, who died Sunday at the age of 96. While she called her autobiography “The First Lady of Plains,” to many she was also the first lady of mental health reform. Decades ago, she took bold stances on mental health topics that, today, have become conventional wisdom: Mental health is health, stigma is deadly, and people with mental illness deserve to be part of society instead of hidden away in overcrow
Pharmaceutical Technology
NOVEMBER 21, 2023
Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 21, 2023
The leadership turmoil within OpenAI, the maker of ChatGPT, is triggering calls for stepped-up efforts to establish standards for how generative AI is used across the health care industry, where experts worry that one or two companies could end up with too much control. Microsoft was already a driving force behind efforts to deploy generative AI in health care.
BioPharma Dive
NOVEMBER 21, 2023
The partnership is another investment by the biotech subsidiary in artificial intelligence for drug discovery and development, continuing an industry trend.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
European Pharmaceutical Review
NOVEMBER 21, 2023
Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. The pharma company stated that if successful, it has the potential to reduce greenhouse gas emissions from use of the inhaler by approximately 90 percent. According to GSK, thirty-five million patients with respiratory conditions globally relying on its metered dose inhaler.
STAT
NOVEMBER 21, 2023
If Paul Grand weren’t the CEO of MedTech Innovator, the largest medical device accelerator in the world, he might have been a keychain salesman. Maybe a producer of the X-Files. Or even invented Quizlet. The son of a teacher and a dentist, Grand graduated from selling neighbors keychains and washing cars as a little kid to programming software that made his parents’ lives easier.
BioPharma Dive
NOVEMBER 21, 2023
Studying somatic mutations could be “the next wave of opportunity” to develop more precise medicines, said Mike Stratton, one of Quotient’s scientific co-founders.
STAT
NOVEMBER 21, 2023
Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom. Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
NOVEMBER 21, 2023
SMPaeds2 aims to advance precision medicines for children with relapsed cancer - News - PharmaTimes
STAT
NOVEMBER 21, 2023
LONDON — An experimental blood cancer drug from MorphoSys hit its primary target in a pivotal trial, the company announced late Monday, but the drug faltered in addressing patient symptoms, causing the company’s stock to fall in early Tuesday trading. In the Phase 3 trial, the German company was testing its drug candidate pelabresib combined with the drug Jakafi against a Jakafi-placebo duo in patients with newly diagnosed myelofibrosis, a type of rare blood cancer.
Pharma Times
NOVEMBER 21, 2023
Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes - News - PharmaTimes
STAT
NOVEMBER 21, 2023
Hello, everyone. Damian Garde here, filling in for Ed Silverman on what is an abbreviated work week here in the U.S., where the holiday discourse has pivoted from how to deal with quarrelsome relatives to whether a certain overexposed obesity treatment is ruining the apparently hallowed tradition of consuming more food than you need. If your personal geography spares you from all this, perhaps consider giving some thanks.
The Pharmacist
NOVEMBER 21, 2023
More work needs to be done to equip pharmacists and their teams with the knowledge, skills and attitudes to mitigate the threat of antimicrobial resistance (AMR) and foster antimicrobial stewardship (AMS), the International Pharmaceutical Federation (FIP) has said in a new report. Published to coincide with World Antimicrobial Resistance Awareness Week (18-24 November), the ‘Antimicrobial […] The post Call for strengthening of education on antimicrobial resistance and stewardship appeared
STAT
NOVEMBER 21, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at an ambitious genomics startup, some cautious optimism on Wall Street, and a rough day for an American in Germany.
The Pharmacist
NOVEMBER 21, 2023
The British Generic Manufacturers Association (BGMA) has questioned the detail of the newly agreed voluntary scheme for branded medicines pricing, access and growth (VPAG), warning that price erosion calculations could damage competition and lead to drug shortages. The government hailed the new VPAG agreement with NHS England and the Association of the British Pharmaceutical Industry […] The post VPAG rebate calculations risk NHS drug shortages, warns BGMA appeared first on The Pharmacist.
European Pharmaceutical Review
NOVEMBER 21, 2023
BRUKINSA ® (zanubrutinib) in combination with the anti-CD20 monoclonal antibody obinutuzumab, has been approved by the European Commission (EC) to treat relapsed or refractory follicular lymphoma in individuals who have received at least two prior lines of systemic therapy. The oral treatment is now “the first Bruton’s tyrosine kinase (BTK) inhibitor approved in this indication and has the broadest label of any medicine in its class globally,” stated Dr Mehrdad Mobasher, Chief Medical Officer, H
BioPharma Dive
NOVEMBER 21, 2023
Surging demand for GLP-1 agonists has put medtech firms like Medtronic under pressure, even as they argue the hit to their businesses will be minimal.
pharmaphorum
NOVEMBER 21, 2023
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that specialises in immunometabolism – a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.
Pharmaceutical Technology
NOVEMBER 21, 2023
According to several key opinion leaders (KOLs) interviewed by GlobalData, pipeline gene therapy holds the greatest potential to transform the Gaucher disease landscape
Express Pharma
NOVEMBER 21, 2023
Evive Biotech (Evive), a subsidiary of Yifan Pharmaceutical Co, and Acrotech Biopharma (Acrotech), a wholly-owned subsidiary of Aurobindo Pharma USA, announced that the US Food and Drug Administration (FDA) approved Ryzneuta (Efbemalenograstim alfa) indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutrop
Outsourcing Pharma
NOVEMBER 21, 2023
OSP had a discussion with Tracy Curley, CEO of iSpecimen, and Eric Langlois, chief revenue officer of iSpecimen and Michael Howell,founder of Mountaineer Biosciences, Inc. to discuss a number of issues those working in precision medicine still face.
World Pharma News
NOVEMBER 21, 2023
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Pfizer Inc. (NYSE: PFE) announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Application for XTANDI® (enzalutamide), following FDA expedited development and review programs (Priority Review designation, Fast Track designation, Real-time Oncology Review), based on results from the Phase 3 EMBARK trial.
Outsourcing Pharma
NOVEMBER 21, 2023
Astellas Pharma Inc. and Pfizer Inc. today announced that the companies received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application for small-molecule drug Xtandi (enzalutamide).
Pharmaceutical Technology
NOVEMBER 21, 2023
The FDA's decision on the sBLA for Abecma will be delayed beyond the set PDUFA target date of 16 December.
Outsourcing Pharma
NOVEMBER 21, 2023
CluePoints, a company providing risk-based study execution (RBx) and risk-based quality management (RBQM) software for clinical trials has won the best Contract Research Organization (CRO) in the specialist providers category at Citelineâs 2023 SCRIP Awards.
Pharmaceutical Technology
NOVEMBER 21, 2023
The new scheme will launch in 2024 and aims to save the National Health Service (NHS) £14bn over five years.
Pharmaceutical Commerce
NOVEMBER 21, 2023
IQVIA report explores why these shortages are increasing, and how they can be mitigated.
The Pharmacist
NOVEMBER 21, 2023
The introduction of the Additional Roles Reimbursement Scheme (ARRS) in general practices has resulted in ‘more exhaustion’ for community pharmacy teams who have been faced with increased staff shortages, an influential committee of MPs has been told. During the first sessions of the Health and Social Care Committee’s pharmacy inquiry this morning, it was suggested […] The post ‘Open up’ ARRS funding to community pharmacy, MPs told appeared first on The Pharmacist.
Outsourcing Pharma
NOVEMBER 21, 2023
A partnership combining an integrated drug creation platform with a company specializing in dermatological expertise will deliver life-changing medicines to patients.
pharmaphorum
NOVEMBER 21, 2023
Digital measures for value-based healthcare: Current perspectives Mike.
Express Pharma
NOVEMBER 21, 2023
Strides Pharma Science announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for Levetiracetam Oral Solution USP, 100 mg/mL, from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Keppra Oral Solution, 100 mg/mL of UCB, Inc.
pharmaphorum
NOVEMBER 21, 2023
GSK says new inhaler will help slash its carbon footprint Phil.
BioPharma Dive
NOVEMBER 21, 2023
In a deal worth up to $610 million, Merck will gain a pipeline of neuroscience and rare disease programs from a startup it previously backed.
Expert insights. Personalized for you.
355 
Let's personalize your content